Chemokines and their receptors as potential targets for the treatment of asthma.
about
Chemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte traffickingElevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophagesObesity enhances eosinophilic inflammation in a murine model of allergic asthma.Anti‑inflammatory effects of dihydromyricetin in a mouse model of asthma.Perinatal bisphenol A exposure beginning before gestation enhances allergen sensitization, but not pulmonary inflammation, in adult mice.Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties.The role of adenosine receptors in regulating production of tumour necrosis factor-alpha and chemokines by human lung macrophagesChronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9.Rare aggressive natural killer cell leukemia presented with bone marrow fibrosis - a diagnostic challenge.Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease modelsRegulation of eosinophil trafficking by SWAP-70 and its role in allergic airway inflammationAsthma from a pharmacogenomic point of viewPreventative effect of an herbal preparation (HemoHIM) on development of airway inflammation in mice via modulation of Th1/2 cells differentiation.Mechanisms in allergic airway inflammation - lessons from studies in the mouse.Regulation of G-protein-coupled signaling pathways in allergic inflammation.The hydroxyflavone, fisetin, suppresses mast cell activation induced by interaction with activated T cell membranes.Airway smooth muscle chemokine receptor expression and function in asthmaAllergen-induced bone marrow eosinophilopoiesis and airways eosinophilic inflammation in leptin-deficient ob/ob mice.A biologically inspired lung-on-a-chip device for the study of protein-induced lung inflammation.A polymorphism in the CCL2 chemokine gene is associated with asthma risk: a case-control and a family study in Tunisia.Bufalin Inhibits the Inflammatory Effects in Asthmatic Mice through the Suppression of Nuclear Factor-Kappa B Activity.Increased Systemic Cytokine/Chemokine Expression in Asthmatic and Non-asthmatic Patients with Bacterial, Viral or Mixed Lung Infection.Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model.Cytokines in chronic respiratory diseases.Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma.Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages.Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response.CC-chemokine ligand 4/macrophage inflammatory protein-1β participates in the induction of neuropathic pain after peripheral nerve injury.The effects of nodakenin on airway inflammation, hyper-responsiveness and remodeling in a murine model of allergic asthma.Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
P2860
Q27013008-66E0183D-F69F-4E16-B618-AA6BE4CF1280Q33564601-FA092854-D2EB-4FD4-A1D1-6348DC642093Q33685925-E71E0A78-FDB8-48A1-A7B8-4DFC1A4F8B6EQ33702441-26F05B59-71EA-48C0-A25F-19F91CCD5680Q33724062-BB9375CD-805C-46A3-AE78-3D3F1F724A49Q33734404-2139D6B7-6445-495A-9416-87BF1525F695Q33767229-7DC28A03-6F68-4561-9E9E-B25870A58C9BQ34021220-B06A5A46-9ACA-4AB2-ADDE-1B9C7B2BC48EQ34037341-BFC005AF-3216-4FA6-A7B9-38A35B6ABE09Q34556640-795C2AB1-3776-4BB5-99A8-710AE0095BADQ35703449-B5AB339B-C6E4-46C6-8802-B58534668D65Q36734803-55EA2415-5395-46FB-ADEE-5628C067EEC3Q36976472-466CD7DA-ABFB-4EEF-86F0-4629B88CA33FQ37173306-3BA072B9-3D66-4F15-A2F1-191D11893899Q37204048-EA5AFA21-E9FE-4799-9D29-7EFB209ED698Q37395933-1BBC4420-D612-4C47-B9A8-19C7A5772370Q37414555-E24035FB-21AA-4C7C-B3E5-7EF1EC1DCED8Q38326037-72DF9186-6BDE-4634-A7F6-67AE620129EDQ38931018-641F2A08-45A2-46E8-B7D6-3268C03637FCQ38941097-FB81616C-613F-4FB6-8912-0F1EBC423CF1Q39042497-E0176855-233C-4434-B79D-C6A6D7D8230BQ40342110-D3200F1B-9DDC-4335-9D26-E9AF0277516FQ41035406-19B9AF57-223D-4EC1-B409-0573F07B8101Q42113962-35ACA2DF-6D18-4864-8104-2DAD106DC025Q43268878-68579B10-6E1F-4686-AE54-1A876D630152Q47101484-294190DD-FD0E-4F5F-AE2B-824A796739C4Q51682174-F09AAC69-86AF-48AF-91B6-9C8D8F31FB03Q54313299-D984D661-2257-49B0-A62D-66AF573F8E15Q54333055-9129FBA9-8226-4F11-B5C8-7BE156F45D24Q54618538-B0910927-17AA-42B0-A49A-8F870FD613D0
P2860
Chemokines and their receptors as potential targets for the treatment of asthma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemokines and their receptors as potential targets for the treatment of asthma.
@ast
Chemokines and their receptors as potential targets for the treatment of asthma.
@en
type
label
Chemokines and their receptors as potential targets for the treatment of asthma.
@ast
Chemokines and their receptors as potential targets for the treatment of asthma.
@en
prefLabel
Chemokines and their receptors as potential targets for the treatment of asthma.
@ast
Chemokines and their receptors as potential targets for the treatment of asthma.
@en
P2860
P356
P1476
Chemokines and their receptors as potential targets for the treatment of asthma.
@en
P2093
C Palmqvist
P2860
P304
P356
10.1038/SJ.BJP.0707263
P407
P577
2007-04-30T00:00:00Z